Tahmina Maqbool - Hamdard University - Lecturer

Tahmina Maqbool

Hamdard University

Lecturer

Karachi, Sindh | Pakistan

Main Specialties: Emergency Medicine, Family Medicine, Medical Microbiology, Medical Toxicology, Preventive Medicine, Public Health

Additional Specialties: Biopharmaceutics, Invitro invivo studies

ORCID logohttps://orcid.org/0000-0002-6261-8055


Top Author

Tahmina Maqbool - Hamdard University - Lecturer

Tahmina Maqbool

Introduction

I have an experience of nine years in Biopharmaceutical research from a world renowned organization “International Center for Chemical and Biological Sciences” (HEJ, University of Karachi) and teaching experience of 2.5 years in Hamdard University. It has led me motivating to continue my current position as Lecturer in Hamdard University, the best academia in Pakistan. I would bring an extensive breadth of knowledge in pharmaceutical research with multiple areas of expertise in hospital pharmacy, community pharmacy, formulation development, in vivo, vitro and in preclinical trials. I would like to lead the institute being strategic partner of teaching staff and obtain challenging position in a dynamic institute that’s provide ample opportunity for development of knowledge, skills & attribute also to acquire useful experience thus contributing towards the prosperity of that country & my own professional growth.

Primary Affiliation: Hamdard University - Karachi, Sindh , Pakistan

Specialties:

Additional Specialties:


View Tahmina Maqbool’s Resume / CV

Education

Aug 2018
University of Karachi
Ph.D
Aug 2018
University of Karachi
Ph.D
Feb 2011
University of Karachi
M.Pharm

Experience

Aug 2017
Hamdard University
Lecturer
Nov 2008
International Center for Chemical and Biological Sciences (ICCBS) HEJ, University of Karachi
Manager QA
Jan 2008
Guardian Pharmacy
Pharmacist

Publications

4Publications

48Reads

2Profile Views

A preliminary study to assess knowledge, preferences, and perception of adult population of Karachi about scored and colored oral solid dosage form

African Journal of Pharmacy and Pharmacology

Beyond the pharmacological activity, the differences have been observed in the preferences of solid dosage form on the basis of color and swallowing difficulty in the studies conducted by a different researcher. The aim of the study is to insight the perception of the general population of Karachi about the color, scoring and splitting of tablets. A convenience sampling technique was used to collect data. Knowledge, attitude and practices of the participants regarding oral solid dosage form have been evaluated through a structured close-ended questionnaire. The color perception was pursued by asking questions to the participants about the association of color with effectiveness, identification, safety and onset of action. The scoring perception was also inquired focusing on the association of scoring on the convenience of splitting, their effect on the dose, type of tablet subjected to splitting and further consequences of splitting. Among 426 respondents, 248 participants were not aware of the type of medicine subjected to be splitting. Approximately half of the respondents (N=221) agreed with the point of view that ease of swallowing is one of the reasons for pill-splitting. The study provided preliminary data about color perception, scoring and splitting of tablet dosage form that can be beneficial for future research.

Key words: Scored tablet, color perception, pill splitting, oral solid dosage form, Karachi.

View Article
April 2020
1 Read

A quantitative insight of the interactions of prescribers with pharmaceutical organization's representatives in clinical settings of Karachi.

Integr Pharm Res Pract 2019 4;8:75-83. Epub 2019 Jul 4.

Department of Pharmacy Practice, International Islamic University Malaysia, Pahang, Malaysia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IPRP.S196318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613537PMC
July 2019

The Study Of The Effects Of Antiplatelet Drugs on Hypertensive Patients” Prescription Analysis Study.

FUUAST Journal of Biology

The aim of the present study is to assess the prescribing errors inhypertensive outpatients taking Antiplatelet drugswith other drugs and consequently the frequency and pattern of potential drug-drug interactions. A retrospective study was conductedfrom December 2017-May 2018. The data analysis was carried out by SPSS. Potential drug-drug interactions were determined by Micromedex 2. Severity of errors was evaluated according to NCCMERP (National Coordinating Council for Medication Error Reporting and Prevention). In current study 1142 medication errors (MEs) were trailed in 300 prescriptions. The utmost ubiquitous ME was the patient’s weight not mentioned in (95.3%) prescriptions continued by drug-drug interactions (95%). Diagnosis was missing in (73.3%) prescriptions. The average number of drugs per encounter was 5.64. According to NCCMERP highest number of the prescriptions (n= 193, 64.33%) were fall in category D, followed by category C and I. Out of 300 prescriptions, majority of thedrug-druginteractions (88.33%) were moderate,(56%) minor andmajor drug-drug interactions were present in (11%) prescriptions. The most common drugs responsible for DDIs were Acetyl salicylic acid followed by Atenolol. The most commonly interacting pairs were Acetyl salicylic acid-Clopidogrel168 (56%) followed by Acetyl salicylic acidCaptopril68 (22.66%) and Acetyl salicylic acid-Nitroglycerine38 (12.66). The study indicates the serious deficient of prescription writing skills among the doctors and their outcomes are responsible to promote the irrational use of drugs, high chances of drug-drug interactions and low patient compliance.

View Article
June 2019
1 Read

Development and evaluation of immediate release diclofenac sodium suppositories.

Pak J Pharm Sci 2018 Sep;31(5):1791-1795

Department of Pharmaceutics, Hamdard University, Karachi, Pakistan.

View Article

Download full-text PDF

Source
September 2018
48 Reads
0.950 Impact Factor